Vistagen Therapeutics, Inc. Entity Public Float in USD from Q2 2012 to Q3 2024

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Vistagen Therapeutics, Inc. quarterly Entity Public Float history and growth rate from Q2 2012 to Q3 2024.
  • Vistagen Therapeutics, Inc. Entity Public Float for the quarter ending September 30, 2024 was $81.2M, a 29.5% increase year-over-year.
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Growth (%)

Vistagen Therapeutics, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $81.2M +$18.5M +29.5% Sep 30, 2024 10-K 2025-06-17
Q3 2023 $62.7M +$31.5M +101% Sep 30, 2023 10-K 2024-06-11
Q3 2022 $31.2M -$506M -94.2% Sep 30, 2022 10-K 2023-06-28
Q3 2021 $537M +$485M +945% Sep 30, 2021 10-K 2022-06-23
Q3 2020 $51.4M +$6.01M +13.3% Sep 30, 2020 10-K 2021-06-29
Q3 2019 $45.4M +$4.24M +10.3% Sep 30, 2019 10-K 2020-06-29
Q3 2018 $41.1M +$22.8M +125% Sep 30, 2018 10-K 2019-06-25
Q3 2017 $18.3M -$15.7M -46.2% Sep 30, 2017 10-K 2018-06-26
Q3 2016 $34M +$20.3M +149% Sep 30, 2016 10-K 2017-06-29
Q3 2015 $13.7M +$3.61M +35.8% Sep 30, 2015 10-K 2016-06-24
Q3 2014 $10.1M +$429K +4.44% Sep 30, 2014 10-K 2015-06-29
Q2 2014 $9.66M +$1.34M +16.1% Jun 19, 2014 10-K 2014-06-25
Q4 2013 $9.66M +$1.34M +16.1% Feb 10, 2014 10-Q 2014-02-14
Q3 2013 $9.66M +$1.34M +16.1% Nov 12, 2013 10-Q 2013-11-14
Q2 2013 $8.32M -$13.9M -62.6% Jul 12, 2013 10-K 2013-07-18
Q4 2012 $8.32M Feb 12, 2013 10-Q 2013-02-14
Q3 2012 $8.32M Nov 12, 2012 10-Q 2012-11-14
Q2 2012 $22.2M Jun 28, 2012 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.